Latest Module
What is new? Advanced Technologies and Treatment for Diabetes (ATTD)
This review of the 2026 Diabetes Technology Congress focuses on patient-facing AI, hypoglycaemia and the glycaemic risk index in the clinical care of TI and T2DM patients
The ethical balance between AI and human Intelligence in clinical practice (Clinical lunch chat – On demand)
Dr David Roytowski brings a practitioner’s perspective to the ethics and application of AI
In-time, Insulin Intervention – the right insulin, the right patient – Case study 3
Dr MJ van Staden focuses on balancing glycaemic control with safety in this elderly T2DM patient with co-morbidities


